Crocodile Trader
OP
104237531
:
hmm, u r right Abt volume.. let's see whether they can breakout.. if based on Jan 7/8, Jan 24-31, vol did increase but didn't manage to break the downtrend.. maybe 3rd time is the lucky one?
$Esperion Therapeutics (ESPR.US)$Esperion Therapeutics (ESPR): A High-Growth Opportunity with Potential 10x Returns Esperion Therapeutics (ESPR), currently trading under $2 per share, has been attracting considerable attention from analysts. Recently, three analysts reaffirmed strong "Buy" ratings, with price targets ranging from $5 to $16 per share. Among the nine analysts covering Esperion, seven h...
Crocodile Trader : well...whole market crash..maybe in normal market condition, you could be right...![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)